How to reduce stroke disability rates with just a few dollars? The Lancet just published the answer from Tiantan Hospital.

🩺 [Challenge: The "Secondary Injury" of Stroke]

Stroke is more than a blockage; it triggers a devastating inflammatory storm.

The Tiantan Hospital expert team highlights that post-stroke neuroinflammation is the primary driver of long-term disability, even after successful surgery.

Conventional neuroprotective treatments are often cost-prohibitive for patients in resource-limited regions.

⚖️ [Strategy: Why the Tiantan Team Chose Minocycline?]

Professor Yilong Wang’s team at Tiantan Hospital pivoted to Minocycline, a classic, low-cost antibiotic with hidden neuroprotective potential.

The team identified its ability to act as a "firewall," preventing brain cells from "friendly fire" during inflammation.

This low-cost, high-availability drug was transformed by Tiantan experts into a powerful, equitable weapon against disability.

🛠️ [Execution: The Streamlined "Tiantan Protocol"]
Tiantan experts established a precise clinical path through the EMPHASIS study: initiation within 72 hours of stroke onset.

Method: A simple 4.5-day oral course, eliminating the need for complex medical infrastructure.

Validation: In a trial of 1,724 patients, the team proved this protocol significantly boosts functional independence at 90 days.

This streamlined approach minimizes the financial and operational burden on hospitals worldwide.

✨ [Insight: Global Impact of the Tiantan Model]

This Tiantan Hospital study, published in The Lancet, champions the concept of "Drug Repurposing."

The Tiantan team offers a practical, affordable, and evidence-based solution for clinicians globally.

It represents a significant contribution to health equity, ensuring high-quality stroke care is accessible to all.